Document Detail


Outcomes of Category III DOTS treatment in immunocompetent patients with tuberculosis pleural effusion.
MedLine Citation:
PMID:  23044446     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: To study the efficacy and safety of Category III DOTS treatment (intermittent thrice-weekly rifampicin [RMP], isoniazid [INH] and pyrazinamide for 2 months, followed by RMP and INH for 4 months) under India's Revised National Tuberculosis Control Programme in patients with uncomplicated small unilateral pleural effusion (<1500 ml).
DESIGN: This prospective, multicentre, observational study recruited 351 patients between 2006 and 2010. Patients were regularly followed up clinically as well as with ultrasound examination of the chest.
RESULTS: Successful outcome (clinical response with complete resolution on ultrasound examination at 6 months) was seen in 274 patients (78.1%). Efficacy was 88.9% (excluding defaulters), and 94% among those completing follow-up as per protocol. None of the patients received corticosteroids. Other outcomes included treatment extension (n = 26, 7.4%), default (n = 43, 12.2%), treatment failure (n = 3, 0.9%) and death (n = 3, 0.9%). Seventy-nine mild/moderate adverse events and one treatment-related serious adverse event were noted; one patient developed recurrent drug-induced hepatotoxicity. Two patients (0.7%) had relapse/re-infection at 24 months follow-up.
CONCLUSION: Intermittent thrice-weekly treatment for 6 months with three drugs in the intensive phase is effective and safe for unilateral small pleural effusion in immunocompetent patients. Although Category III no longer exists in the programme, the results are reassuring for intermittent treatment in extra-pulmonary TB under programme conditions.
Authors:
S K Sharma; R Solanki; A Mohan; N K Jain; L S Chauhan;
Related Documents :
24392336 - Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure af...
23396886 - Ablation of large hccs using a new saline-enhanced expandable radiofrequency device().
16408556 - Intraoperative use of mitomycin c in fibrous atresia of the external auditory canal.
23934676 - Long term efficacy of radioiodine treatment in hyperthyroidism.
24021266 - Modification of the syme amputation to prevent postoperative heel pad migration.
19597646 - Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  16     ISSN:  1815-7920     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  1505-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia.
Next Document:  Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosi...